Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
A longitudinal cohort study of sexually active women 18-30 years of age was conducted to identify variables associated with the acquisition of herpes simplex virus type 2 (HSV-2) infections. Six hundred seventy HSV-2-seronegative women were followed up at 4-month intervals for 1 year; acquisition of HSV-2 antibodies was detected in 32 of these women. Black race, < or =12 years of education, having a new sex partner, and bacterial vaginosis (BV) were associated with HSV-2 seroconversion on univariate analysis. Antecedent HSV-1 infection was not protective against HSV-2 acquisition. After controlling for other identified risk factors in multivariable models, the diagnosis of BV remained associated with an increased risk of acquiring HSV-2 infection (hazard ratio, 2.1; 95% confidence interval, 1.0-4.5; P=.05). In this study, the population attributable risk of BV for HSV-2 seroconversion was 21%. Additional studies are needed to determine whether screening and treatment of BV could reduce susceptibility to the acquisition of HSV-2 in women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As the normal vaginal microbiota is protective against the acquisition of STI,26–29 and HIV,30 31 menstrual cups may have the potential to reduce the incidence of such infections in vulnerable girls and the spread to their partners.”
Citations
Cites
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331 · cited 1×
“Vaginal smears were Gram-stained and evaluated for BV according to a standardized 0–10-point scoring system [10].”
MethodSelf-citationThe social organization of sexuality: sexual practices in the United States
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4802a · Cited by 2,890
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
Martin, H. L., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B., Mandaliya, K., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 891
Self-citationHIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
Sewankambo, N., Gray, R. H., Wawer, M. J., Paxton, L., McNairn, D., Wabwire-Mangen, F., Serwadda, D., Li, C., Kiwanuka, N., Hillier, S. L., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01063-5 · Cited by 655 · cited 1×
“Because the prevalence of BV among women in some communities can be as high as 50% [14], it seems likely that more-comprehensive screening and appropriate treatment of BV would reduce susceptibility to the acquisition of HSV-2 among women.”
BackgroundSelf-citationBacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV
Taha, T. E., Hoover, D. R., Dallabetta, G. A., Kumwenda, N. I., Mtimavalye, L. A. R., Yang, L.-P., Liomba, G. N., Broadhead, R. L., Chiphangwi, J. D., & Miotti, P. G. (1998) · AIDS · doi:10.1097/00002030-199813000-00019 · Cited by 634
Diffusion of Macromolecules and Virus-Like Particles in Human Cervical Mucus
Olmsted, S. S., Padgett, J. L., Yudin, A. I., Whaley, K. J., Moench, T. R., & Cone, R. A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75844-4 · Cited by 544 · cited 1×
“In vitro, cervical mucus has demonstrated the ability to trap HSV in its viscous gel [17].”
BackgroundAshley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541 · cited 1×
“For samples in which antibodies to HSV-2 were found by ELISA (and on serum samples from the visits that immediately preceded and followed ELISA seroconversion), Western blot (WB) analysis was performed by the University of Washington Virology Laboratory (Seattle), using methods described elsewhere [12].”
MethodA Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 510 · cited 1×
“Likewise, the Chiron HSV Vaccine Study Group found that previous HSV-1 infection increased the likelihood of asymptomatic HSV-2 seroconversion but did not reduce the rate of HSV-2 acquisition [23].”
Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections
Wald, A., Zeh, J., Selke, S., Ashley, R. L., & Corey, L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331205 · Cited by 507 · cited 1×
“sociated with higher rates of vaginal shedding of virus [13].”
Background
Research works printed but not linked: 3
- Mindel, 1996, Scandinavian journal of infectious diseases. Supplementum, 100, 27
- Mertz, 1992, Annals of Internal Medicine, 116, 197, 10.1059/0003-4819-116-3-197 · doi:10.1059/0003-4819-116-3-197
- Siegel, 1992, JAMA, 268, 1702, 10.1001/jama.1992.03490130090036 · doi:10.1001/jama.1992.03490130090036
Cited by
Items 401–415 of 415
Gram-positive bacterial cell wall components inhibit herpes simplex virus infectionPreprint
Adams, A. N. D., Griffin, L. E., Burnie, J., Powers, J., Causey, A., Glick, V. J., Gavitt, M., Richmond-Buccola, D., Kim, C. H., Ahmad, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.02.686169
“…viral infections including human immunodeficiency virus HIV (Atashili et al., 2008; Borgdorff et al., 2014) human papilloma virus (Qi et al., 2024), and HSV (Cherpes et al., 2003, 2005), suggesting that the presence of Lactobacillus decreases the risk of vaginal viral infections in humans.”
Study of the vaginal and rectal microflora in pregnant women, with emphasis on Group B streptococci
Aila, N. A. E. (2011) · Ghent University Academic Bibliography (Ghent University)
Kestelyn, E. (2024) · Open Research Online (The Open University) · doi:10.21954/ou.ro.00097645
The Nugent score is an inappropriate diagnostic tool for neovaginal bacteria in transfeminine people
Parmar, R., Monari, B., Potter, E., Rojas-Vargas, J., Wilcox, H., Zuanazzi, D., Poon, A., Shouldice, A. C., Edwards, V. L., Krakowsky, Y., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01410-2
“Even without symptoms, non-optimal microbiomes in rCF are associated with increased susceptibility to sexually transmitted infections, including chlamydia, gonorrhea, HSV-2, and HIV-1, underscoring the importance of the vaginal microbiome in sexual health 14 – 23 .”
Risk of HSV-2 Acquisition Among Women with Bacterial Vaginosis: Systematic Review and Meta-Analysis
Whitt, T. N., Heath, A. E., Hill, D. J., Brubaker, D. K., & Zuend, C. F. (2026) · Viruses · doi:10.3390/v18030330
Tamarelle, J. (2019) · theses.fr (ABES) · doi:10.70675/03d2627bz0b41z4fd3z9442z3e32953d7d56 · Cited by 1
Udayakumar, S., Pollock, J., Irungu, E., Muthoga, P., Adhiambo, W., Huibner, S., Kungu, M., Kabuti, R., Babu, H., Champions, M. F. S., et al. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70273
“After controlling for potential confounders such as BV, which causes epithelial disruption and has been linked to HSV-2 [ 13, 28 ], we find no soluble immune associations of seroprevalent HSV-2 infection.”
InfluentialMcCullough, E., Zulaika, G., Osire, E. A., Akinyi, C., Otieno, F., Phillips‐Howard, P. A., Mehta, S. D., & Mason, L. (2026) · Women s Health · doi:10.1177/17455057261465644
Celeste, C., Sokolik, C. C., Gachunga, W., & Parker, I. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014767
Vaginal Virome and Preterm Birth (See companion study SDY1206)
Stout, M. (2019) · ImmPort · doi:10.21430/m31k9qn0om
Qi, F., Fan, S., Fang, C., Ge, L., Lyu, J., Huang, Z., Zhao, S., Zou, Y., Huang, L., Liu, X., et al. (2023) · doi:10.3389/fimmu.2023.1125239.s001
Thurman, A. R., Ravel, J., Gajer, P., Marzinke, M. A., Ouattara, L. A., Jacot, T., Peet, M. M., Clark, M. R., & Doncel, G. F. (2022) · doi:10.3389/fcimb.2022.799501.s005
Ssemaganda, A., Cholette, F., Perner, M., Kambaran, C., Adhiambo, W., Wambugu, P. M., Gebrebrhan, H., Lee, A., Nuhu, F., Mwatelah, R. S., et al. (2021) · doi:10.3389/fimmu.2021.726472.s001
Metadata
- Authors
- Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., & Hillier, S. L.
- Affiliations
- University of Pittsburgh (US)
- Magee-Womens Research Institute (US)
- Corresponding author
- Meyn, L. A.
- ORCID
- Krohn, M. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-01
- Volume
- 37
- Issue
- 3
- Pages
- 319-325
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2095874292
- Cited by
- 415
- References
- 31
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 14 · 2023: 17 · 2022: 23 · 2021: 15 · 2020: 24 · 2019: 22 · 2018: 23 · 2017: 27 · 2016: 22 · 2015: 20 · 2014: 21 · 2013: 28 · 2012: 16
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington
- U.S. Public Health Service (N01-A1-75326)
- National Institute of Allergy and Infectious Diseases (T32-AI07333, U01-AI46745, T32AI007333, U01AI046745)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- herpes simplex virus type 2, bacterial vaginosis, HSV-1 infection, Black women, educational attainment, new sexual partners, population attributable risk
- MeSH terms
- Adult, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Herpes Simplex, Humans, Longitudinal Studies, Pregnancy, Risk Factors, Cohort Studies, Polymerase Chain Reaction, Vaginosis, Bacterial, Herpesvirus 2, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.